Who should use the Analyze genomic data to find potential drug targets workflow?
Teams or solo builders working on science & healthcare tasks who want a repeatable process instead of one-off tool experiments.
AI Workflow · Science & Healthcare
Practical execution plan for analyze genomic data to find potential drug targets with clear steps, mapped tools, and delivery-focused outcomes.
Deliverable outcome
Actionable report with prioritized, validated drug targets and experimental roadmap
30-90 minutes
Includes setup plus initial result generation
Free to start
You can swap tools by pricing and policy requirements
Actionable report with prioritized, validated drug targets and experimental roadmap
Use each step output as the input for the next stage
Step map
Instead of relying on a single generic AI model, this pipeline connects specialized tools to maximize quality. First, you'll use Tempus to curated, high-quality genomic dataset ready for differential analysis. Then, you pass the output to Tempus to prioritized list of genes significantly altered in disease. Then, you pass the output to BERG (BPGbio) to ranked shortlist of druggable gene targets with pathway context. Then, you pass the output to TrendSpider to clinically and functionally validated target candidates with supporting evidence. Finally, Anaconda is used to actionable report with prioritized, validated drug targets and experimental roadmap.
Acquire and curate genomic datasets
Curated, high-quality genomic dataset ready for differential analysis
Identify differentially expressed genes or mutated genes
Prioritized list of genes significantly altered in disease
Prioritize drug-targetable genes using functional and network analysis
Ranked shortlist of druggable gene targets with pathway context
Validate target relevance with clinical and functional data
Clinically and functionally validated target candidates with supporting evidence
Generate final target report and propose next steps
Actionable report with prioritized, validated drug targets and experimental roadmap
Identify and download relevant genomic datasets (e.g., tumor vs. normal, disease vs. control) from public repositories like TCGA, GEO, or ENA. Perform quality control using FastQC, trim adapters with Trimmomatic, and align reads to a reference genome using STAR or BWA. Ensure data is properly annotated and stored in a structured format (e.g., BAM, VCF).
Why Tempus: Tempus offers genomic profiling and drug target discovery, directly aligning with acquiring and curating genomic datasets for target identification.
Perform differential expression analysis (e.g., DESeq2 for RNA-seq) or mutation frequency analysis (e.g., MutSig2CV) to find genes significantly altered in disease versus control. Filter results by statistical significance (adjusted p-value < 0.05) and effect size (log2 fold change > 1 or mutation rate > 5%). Generate a ranked list of candidate genes.
Why Tempus: Tempus's genomic profiling capabilities can identify differentially expressed genes or mutations, supporting the analysis needed for this step.
Map candidate genes to known drug-target databases (DrugBank, ChEMBL) and assess druggability (e.g., enzyme, receptor, ion channel). Perform pathway enrichment (KEGG, Reactome) and protein-protein interaction network analysis (STRING, Cytoscape) to identify hub genes and disease-relevant pathways. Rank genes by druggability score and network centrality.
Why BERG (BPGbio): BERG (BPGbio) specializes in target identification and validation, aligning with prioritizing drug-targetable genes through functional analysis.
Cross-reference prioritized targets with clinical outcome data (e.g., survival analysis from TCGA) and functional genomics databases (e.g., DepMap for CRISPR essentiality, GTEx for tissue expression). Confirm that target expression correlates with disease severity or prognosis, and that knockdown/knockout impairs disease cell viability.
Why TrendSpider: Tempus provides clinical trial matching and genomic profiling, directly supporting validation of target relevance with clinical data.
Compile a structured report listing the top 5-10 validated drug targets, each with rationale (differential expression, druggability, pathway, clinical correlation). Include visualizations (volcano plots, network diagrams, survival curves). Propose experimental validation (e.g., CRISPR knockout, in vitro assays) and potential drug repurposing or screening strategies.
Why Anaconda: Dotmatics Scientific Intelligence Platform provides data management and AI-driven prediction, which can support generating reports and visualizing results.
§ Before you start
Teams or solo builders working on science & healthcare tasks who want a repeatable process instead of one-off tool experiments.
No. Start with the top pick for each step, then replace tools only if they do not fit your pricing, compliance, or output needs.
Open the mapped task page and compare top options side by side. Prioritize output quality, integration fit, and predictable cost before scaling.
§ Related
Track competitor moves and market shifts in real-time with automated intelligence gathering — so you always know what your rivals are doing.
Connect siloed business applications into a unified, AI-managed operational pipeline that eliminates manual handoffs between systems.
Analyze portfolios, backtest investment strategies, and receive AI-generated market signals — giving individual investors access to institutional-grade tools.